Cancer cells may soon be turned into their own treatment factories. Researchers have found a way to use carbon monoxide, a gas that tumor cells naturally produce, as raw material for drugs that are made directly inside the cancer itself. The goal is to attack tumors while leaving healthy tissue largely untouched, a problem that has long limited conventional chemotherapy.
The approach works by exploiting a feature of tumors that distinguishes them from normal tissue. Because cancer cells generate carbon monoxide as part of their abnormal activity, scientists can design compounds that react with that gas once they reach the tumor, so the toxic agent forms where it is needed rather than circulating throughout the body. In principle, this would limit the collateral damage that makes standard chemotherapy so hard on patients.
So far, the findings come from early laboratory experiments, and the results remain at the level of cells and models rather than people. No human testing has been reported, so it is too early to say whether the method will be safe or effective in patients. Even so, the research points toward a possible alternative to conventional chemotherapy, and scientists will need to demonstrate both its precision and its safety before it can be considered for clinical use.